163 related articles for article (PubMed ID: 38627724)
1. Impact of grade on workup of rectal neuroendocrine tumors: a retrospective cohort study : Grade impact on workup of rectal NETs.
Watanabe A; Rai S; Yip L; Brown CJ; Loree JM; Stuart HC
World J Surg Oncol; 2024 Apr; 22(1):98. PubMed ID: 38627724
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic characteristics and prognosis of rectal neuroendocrine neoplasms].
Liu T; Liu P; Wu T; Pan Y; Chen G; Wang P; Jiang Y; Wu Y; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):1015-1019. PubMed ID: 28900992
[TBL] [Abstract][Full Text] [Related]
3. Prediction of the World Health Organization Grade of rectal neuroendocrine tumors based on CT histogram analysis.
Liang P; Xu C; Tan F; Li S; Chen M; Hu D; Kamel I; Duan Y; Li Z
Cancer Med; 2021 Jan; 10(2):595-604. PubMed ID: 33263225
[TBL] [Abstract][Full Text] [Related]
4. Grade is a Dominant Risk Factor for Metastasis in Patients with Rectal Neuroendocrine Tumors.
Folkert IW; Sinnamon AJ; Concors SJ; Bennett BJ; Fraker DL; Mahmoud NN; Metz DC; Stashek KM; Roses RE
Ann Surg Oncol; 2020 Mar; 27(3):855-863. PubMed ID: 31701298
[TBL] [Abstract][Full Text] [Related]
5. [Analysis of clinicopathological characteristics, therapeutic strategy and prognosis of 501 patients with gastric neuroendocrine neoplasms attending a single center].
Zhang BL; Lu YX; Liang WQ; Gao YH; Xi HQ; Wang XX; Zhang KC; Chen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2023 May; 26(5):459-466. PubMed ID: 37217354
[No Abstract] [Full Text] [Related]
6. Predictive Factors for Lymph Node Metastasis and Prognostic Factors for Survival in Rectal Neuroendocrine Tumors.
Sohn B; Kwon Y; Ryoo SB; Song I; Kwon YH; Lee DW; Moon SH; Park JW; Jeong SY; Park KJ
J Gastrointest Surg; 2017 Dec; 21(12):2066-2074. PubMed ID: 29047070
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Factors for Locoregional Recurrence in Neuroendocrine Tumors of the Rectum.
Tsang ES; McConnell YJ; Schaeffer DF; Yin Y; Speers CH; Kennecke HF
Dis Colon Rectum; 2018 Feb; 61(2):187-192. PubMed ID: 29337773
[TBL] [Abstract][Full Text] [Related]
8. Staging System for Neuroendocrine Tumors of the Lung Needs to Incorporate Histologic Grade.
Jackson AS; Rosenthal A; Cattoni M; Bograd AJ; Farivar AS; Aye RW; Vallières E; Louie BE
Ann Thorac Surg; 2020 Apr; 109(4):1009-1018. PubMed ID: 31706866
[TBL] [Abstract][Full Text] [Related]
9. Survival Analyses for Patients With Surgically Resected Pancreatic Neuroendocrine Tumors by World Health Organization 2010 Grading Classifications and American Joint Committee on Cancer 2010 Staging Systems.
Yang M; Ke NW; Zhang Y; Zeng L; Tan CL; Zhang H; Mai G; Tian BL; Liu XB
Medicine (Baltimore); 2015 Dec; 94(48):e2156. PubMed ID: 26632896
[TBL] [Abstract][Full Text] [Related]
10. Essentiality of Imaging Diagnostic Criteria Specific to Rectal Neuroendocrine Tumors for Detecting Metastatic Lymph Nodes.
Kudou M; Arita T; Nakanishi M; Kuriu Y; Murayama Y; Shoda K; Kosuga T; Konishi H; Morimura R; Shiozaki A; Ikoma H; Kubota T; Fujiwara H; Okamoto K; Otsuji E
Anticancer Res; 2019 Jan; 39(1):505-510. PubMed ID: 30591502
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive validation of the novel 8th edition of American Joint Committee on Cancer staging manual for the long-term survivals of patients with non-functional pancreatic neuroendocrine neoplasms.
Yang M; Zeng L; Yao WQ; Ke NW; Tan CL; Tian BL; Liu XB; Xiang B; Zhang Y
Medicine (Baltimore); 2020 Nov; 99(46):e22291. PubMed ID: 33181635
[TBL] [Abstract][Full Text] [Related]
12. Clinical and prognostic features of rectal neuroendocrine tumors.
Weinstock B; Ward SC; Harpaz N; Warner RR; Itzkowitz S; Kim MK
Neuroendocrinology; 2013; 98(3):180-7. PubMed ID: 24080744
[TBL] [Abstract][Full Text] [Related]
13. Risk Factor Analysis of Lymph Node Metastasis for Rectal Neuroendocrine Tumors: Who Needs a Radical Resection in Rectal Neuroendocrine Tumors Sized 1-2 cm?
Choi JS; Kim MJ; Shin R; Park JW; Heo SC; Jeong SY; Park KJ; Ryoo SB
Ann Surg Oncol; 2024 Apr; 31(4):2414-2424. PubMed ID: 38194045
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the Impact of 68Ga-DOTATATE and 18F-FDG PET/CT on Clinical Management in Patients with Neuroendocrine Tumors.
Panagiotidis E; Alshammari A; Michopoulou S; Skoura E; Naik K; Maragkoudakis E; Mohmaduvesh M; Al-Harbi M; Belda M; Caplin ME; Toumpanakis C; Bomanji J
J Nucl Med; 2017 Jan; 58(1):91-96. PubMed ID: 27516446
[TBL] [Abstract][Full Text] [Related]
15. Endoscopic management of 345 small rectal neuroendocrine tumours: A national study from the French group of endocrine tumours (GTE).
Fine C; Roquin G; Terrebonne E; Lecomte T; Coriat R; Do Cao C; de Mestier L; Coffin E; Cadiot G; Nicolli P; Lepiliez V; Hautefeuille V; Ramos J; Girot P; Dominguez S; Céphise FV; Forestier J; Hervieu V; Pioche M; Walter T
United European Gastroenterol J; 2019 Oct; 7(8):1102-1112. PubMed ID: 31662867
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.
Zhou Z; Wang Z; Zhang B; Wu Y; Li G; Wang Z
Front Endocrinol (Lausanne); 2021; 12():727327. PubMed ID: 34539577
[TBL] [Abstract][Full Text] [Related]
17. Clinical and pathological characteristics and prognosis of 132 cases of rectal neuroendocrine tumors.
Yu YJ; Li YW; Shi Y; Zhang Z; Zheng MY; Zhang SW
World J Gastrointest Oncol; 2020 Aug; 12(8):893-902. PubMed ID: 32879666
[TBL] [Abstract][Full Text] [Related]
18. Rectal neuroendocrine tumors in a colon cancer screening colonoscopy program. Sixteen-year single institution experience.
Dąbkowski K; Michalska K; Rusiniak-Rosińska N; Urasińska E; Bielicki D; Starzyńska T
Scand J Gastroenterol; 2023 Mar; 58(3):310-313. PubMed ID: 36121191
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine Tumor Heterogeneity Adds Uncertainty to the World Health Organization 2010 Classification: Real-World Data from the Spanish Tumor Registry (R-GETNE).
Nuñez-Valdovinos B; Carmona-Bayonas A; Jimenez-Fonseca P; Capdevila J; Castaño-Pascual Á; Benavent M; Pi Barrio JJ; Teule A; Alonso V; Custodio A; Marazuela M; Segura Á; Beguiristain A; Llanos M; Martinez Del Prado MP; Diaz-Perez JA; Castellano D; Sevilla I; Lopez C; Alonso T; Garcia-Carbonero R
Oncologist; 2018 Apr; 23(4):422-432. PubMed ID: 29330208
[TBL] [Abstract][Full Text] [Related]
20. Sporadic Gastric Well-Differentiated Neuroendocrine Tumors Have a Higher Ki-67 Proliferative Index.
Lee HE; Mounajjed T; Erickson LA; Wu TT
Endocr Pathol; 2016 Sep; 27(3):259-67. PubMed ID: 27306997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
